/ Not yet recruiting临床1/2期IIT A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N-ACETYLCYSTEINE TOGETHER WITH RILUZOLE IN AMBULANT PATIENTS DIAGNOSED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) - NADALS-001-ALS -2021
/ Not yet recruiting临床3期IIT Efficacy of subcutaneous butylscopolamine vs placebo for control to death rattle in agony. Randomized clinical trial. - the ECABUSCA12 trial
/ Not yet recruiting临床2期IIT Gabapentin int he disorder of the impulse control in the Parkinson´s Disease: multicentric study, double-blind, randomized, controlled with placebo. - IMULPARK
100 项与 Asociacion Instituto Biodonostia 相关的临床结果
0 项与 Asociacion Instituto Biodonostia 相关的专利（医药）
100 项与 Asociacion Instituto Biodonostia 相关的药物交易
100 项与 Asociacion Instituto Biodonostia 相关的转化医学
